Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06410547
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-04-24
Brief Title:
Processing of Routine Clinical Data Using Large Language Models Such As GPT-4
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Processing of Routine Clinical Data Using Large Language Models Such As GPT-4
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMPL-AI-MENT
Brief Summary:
According to studies in the US and the Netherlands 33-40 of patients with chronic conditions receive care that does not follow guideline recommendations These findings have also been demonstrated in the management of COPD This leads to under- or over-treatment of patients and in the case of COPD to exacerbations and hospitalisations These exacerbations are a significant clinical problem affecting patients lung function quality of life and mortality They are also a burden on the healthcare system Technological advances in artificial intelligence offer the opportunity to address these issues in COPD management In the past year there have been remarkable innovations in the field of natural language processing especially through large language models such as GPT-4 from OpenAI and Bard or Gemini from Google These models offer an opportunity to improve the implementation of evidence-based care in clinical practice
This study is a prospective randomised trial that will compare therapy on discharge for patients with COPD One arm will receive no intervention while the other arm will receive a treatment recommendation from an LLM The study will compare the percentage of patients treated according to the guideline
This study is a prospective randomised trial that will compare therapy on discharge for patients with COPD One arm will receive no intervention while the other arm will receive a treatment recommendation from an LLM The study will compare the percentage of patients treated according to the guideline
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None